Duality Advisers’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-59,916
| Closed | -$2.12M | – | 250 |
|
|
2024
Q1 | $2.12M | Buy |
59,916
+30,484
| +104% | +$1.08M | 0.21% | 173 |
|
|
2023
Q4 | $1.28M | Buy |
29,432
+7,252
| +33% | +$316K | 0.14% | 264 |
|
|
2023
Q3 | $847K | Sell |
22,180
-18,634
| -46% | -$712K | 0.1% | 324 |
|
|
2023
Q2 | $1.68M | Buy |
+40,814
| New | +$1.68M | 0.21% | 189 |
|
|
2022
Q4 | – | Sell |
-36,123
| Closed | -$1.53M | – | 670 |
|
|
2022
Q3 | $1.53M | Buy |
36,123
+25,912
| +254% | +$1.1M | 0.17% | 236 |
|
|
2022
Q2 | $552K | Buy |
10,211
+2,330
| +30% | +$126K | 0.05% | 447 |
|
|
2022
Q1 | $506K | Sell |
7,881
-3,489
| -31% | -$224K | 0.05% | 468 |
|
|
2021
Q4 | $762K | Sell |
11,370
-19,366
| -63% | -$1.3M | 0.08% | 340 |
|
|
2021
Q3 | $2.11M | Buy |
30,736
+17,582
| +134% | +$1.2M | 0.16% | 238 |
|
|
2021
Q2 | $898K | Buy |
+13,154
| New | +$898K | 0.08% | 348 |
|
|
2020
Q4 | – | Sell |
-28,200
| Closed | -$1.33M | – | 631 |
|
|
2020
Q3 | $1.33M | Buy |
28,200
+19,745
| +234% | +$933K | 0.09% | 304 |
|
|
2020
Q2 | $397K | Buy |
+8,455
| New | +$397K | 0.04% | 328 |
|
|
2020
Q1 | – | Sell |
-11,584
| Closed | -$675K | – | 155 |
|
|
2019
Q4 | $675K | Sell |
11,584
-266
| -2% | -$15.5K | 0.04% | 312 |
|
|
2019
Q3 | $712K | Buy |
+11,850
| New | +$712K | 0.04% | 273 |
|